drugset / Trial / NCT05188664
Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
A Phase I/II, Open-Label, Multiple Centre Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of LM- 302 in Combination with Toripalimab in Patients with Advanced Solid Tumors
Timeline
- Start
- 2022-05-10
- Primary completion
- 2023-11-14
- Completion
- 2023-11-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TPX4589 | Other / unclassified | — | Intravenous |
| Subject | Toripalimab | Monoclonal antibody | — | Intravenous |